Betta Biologic

Betta Pharmaceuticals is a leading Chinese pharmaceutical company specializing in the discovery, development, and commercialization of innovative oncology therapies. The company gained significant prominence with the launch of icotinib (Conmana), the first self-developed small molecule targeted anti-cancer drug in China. Betta Pharmaceuticals maintains a robust pipeline focused on targeted therapies and immunotherapies, including ALK inhibitors and multi-target kinase inhibitors. Headquartered in Hangzhou, the company operates integrated R&D centers and manufacturing facilities to support its mission of providing affordable, high-quality innovative drugs to patients.